NCT03465943

Brief Summary

The aim of this study was to compare between crystalloid versus crystalloid and colloid combination preloads for prevention of hypotension following intrathecal anaesthesia in patients undergoing elective Caesarean section. To examine weather baseline perfusion index could predict the incidence of intrathecal-induced hypotension during Caesarean section.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Mar 2018

Shorter than P25 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 15, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

March 15, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

March 3, 2018

Last Update Submit

March 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of hypotension

    Decrease in systolic blood pressure more than 20% of base line

    1 hour

Secondary Outcomes (3)

  • Perfusion index

    1 hour

  • Heart rate

    1 hour

  • Urine output

    1 hour

Study Arms (2)

Ringer

ACTIVE COMPARATOR

This group will receive 1 L of Ringer's solution as a preload

Drug: Ringer

Voluven

ACTIVE COMPARATOR

This group will receive 500 ml of 6% hydroxyethyl starch ( Voluven ) and 500 ml Ringer's solution as a preload

Drug: RingerDrug: Voluven

Interventions

RingerDRUG

1L of Ringer's solution as a preload in one group.

Also known as: Crystalloid
RingerVoluven

500 ml of voluven will be given in combination with 500 ml Ringer's solution as a preload in the other group.

Also known as: Hydroxyethyl starch 6%
Voluven

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age : 18-40 years
  • ASA 1\&2

You may not qualify if:

  • Patients with morbid obesity.
  • Pre-existing or pregnancy-induced hypertension.
  • Known cardiovascular or cerebrovascular disease.
  • Abnormal CTG tracing.
  • Any other contraindications for intrathecal anaesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Ripolles Melchor J, Espinosa A, Martinez Hurtado E, Casans Frances R, Navarro Perez R, Abad Gurumeta A, Calvo Vecino JM. Colloids versus crystalloids in the prevention of hypotension induced by spinal anesthesia in elective cesarean section. A systematic review and meta-analysis. Minerva Anestesiol. 2015 Sep;81(9):1019-30. Epub 2014 Dec 11.

    PMID: 25501602BACKGROUND
  • Ngan Kee WD. Confidential enquiries into maternal deaths: 50 years of closing the loop. Br J Anaesth. 2005 Apr;94(4):413-6. doi: 10.1093/bja/aei069. No abstract available.

MeSH Terms

Conditions

Hypotension

Interventions

Crystalloid SolutionsHES 130-0.4

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Isotonic SolutionsSolutionsPharmaceutical Preparations

Central Study Contacts

Essam E. Abd El-Hakeem, PhD

CONTACT

Nagwa Mostafa Osman, PhD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 3, 2018

First Posted

March 15, 2018

Study Start

March 1, 2018

Primary Completion

March 1, 2019

Study Completion

April 1, 2019

Last Updated

March 15, 2018

Record last verified: 2018-03